Closed System Solutions For Tackling Cell And Gene Therapy Manufacturing Risks

Cell therapy manufacturers are tackling the treatment of severe and rare diseases, but high costs stemming from the manufacturing variability and contamination risk often stand in their way when working with these products. Corning's closed system solutions can help you assess the risk of contamination. This presentation looks into the benefits of a closed system approach, what makes it unique, and how implementing this approach could improve your process development and manufacturing.